MedPath

Benefit of positons emission tomography / 68Gallium citratetomodensitometry for artificial hip and knee chronic infection diagnosis

Phase 1
Conditions
Prosthetic joint infection
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
Registration Number
CTIS2024-515781-13-00
Lead Sponsor
Centre Hospitalier Universitaire De Bordeaux
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

Patients aged over 18 years old, Patient adressed for the first time to reference center for joint prosthesis infection (CRIOA, infectious diseases unit and orthopedic surgery unit) for suspicion of first episode of artificial hip or knee infection, Suspicion of artificial joint infection starting at least one month before evaluation., Patient for who routine diagnosis includes screaning by both bone scintigraphy and polynuclear scintigraphy., Patient with positive bone scintigraphy, Being affiliated to a health insurance system, Having signed an informed consent form (later than the day of inclusion and before any examination required by the research)

Exclusion Criteria

Patient with progressive cancer, Patient with negative bone scintigraphy, Patient who cannot stop antibiotic for 14 days because of his state of health, Pregnant or breastfeeding women, Women of childbearing age but not using effective means of contraception, Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent), Subject in relative exclusion period from another protocol, Known contraindications to PET exam with radio tracer injection (hypersensitivity to radiopharmaceutical and/or to excipients)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath